Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY10 | O00398 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.35 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.35 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.35 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.35 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | GPR174 | Q9BXC1 | 3/20 | 0.34 |
| ▸ | GPR34 | Q9UPC5 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 3/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19320498 | 1.00 | P2RY10 (0.36) | P2RY10ALDH1A1EPHX2MEN1GAA | |
| SCHEMBL15430205 | 0.90 | GAA (0.35) | ALDH1A1MEN1GAAKMT2AMAPT | |
| SCHEMBL19305829 | 0.89 | ALDH1A1 (0.35) | P2RY10ALDH1A1EPHX2MEN1GAA | |
| SCHEMBL19305296 | 0.89 | ALDH1A1 (0.35) | P2RY10ALDH1A1EPHX2MEN1GAA | |
| SCHEMBL15430188 | 0.88 | ALOX5 (0.40) | GAAPPARG | |
| SCHEMBL19305828 | 0.86 | P2RY10 (0.36) | P2RY10ALDH1A1EPHX2MEN1GAA | |
| SCHEMBL19305822 | 0.86 | P2RY10 (0.36) | P2RY10ALDH1A1EPHX2MEN1GAA | |
| SCHEMBL19320500 | 0.86 | CYP3A4 (0.38) | ALDH1A1MEN1GAAKMT2ALMNA | |
| SCHEMBL19320502 | 0.86 | GAA (0.39) | ALDH1A1MEN1GAAKMT2ALMNA | |
| SCHEMBL19320499 | 0.84 | GAA (0.36) | ALDH1A1MEN1GAAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170253574-A1 | 3-ARYL-BENZOFURANONE COMPOUND AND COMPOSITION FORMED THEREFROM | EUTEC CHEMICAL CO., LTD (TW) | 2017-09-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253574-A1 | 3-ARYL-BENZOFURANONE COMPOUND AND COMPOSITION FORMED THEREFROM | ZNF436-AS1, THEM6, WASF2 | P2RY10 912/4885ALDH1A1 2062/4885EPHX2 2468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.